MARKET

FMS

FMS

Fresenius Medi
NYSE

Real-time Quotes | Nasdaq Last Sale

30.11
+0.24
+0.80%
Pre Market: 29.78 -0.33 -1.10% 05:45 05/25 EDT
OPEN
30.17
PREV CLOSE
29.87
HIGH
30.29
LOW
29.93
VOLUME
750
TURNOVER
--
52 WEEK HIGH
42.45
52 WEEK LOW
28.06
MARKET CAP
17.65B
P/E (TTM)
18.16
1D
5D
1M
3M
1Y
5Y
Fresenius Medical Care goes ex-dividend tomorrow
Fresenius Medical Care (NYSE:FMS) had declared EUR 1.35/share quarterly dividend, 0.7% increase from prior dividend of EUR 1.34. Payable May 27; for shareholders of record May 16; ex-div May 13.
Seekingalpha · 05/12 15:31
Fresenius Medical Care Celebrates Diversity and Unity of a Global Nurse Workforce
HONG KONG, May 12, 2022--Fresenius Medical Care, the world’s leading provider of products and services for individuals with renal diseases, today announced its global ‘United in Care’ campaign that celebrates the diversity, unity and positive impact of its...
Business Wire · 05/12 07:48
Fresenius Medical (FMS) Q1 Earnings & Revenues Top Estimates
Fresenius Medical's (FMS) first-quarter earnings benefit from strong performance across all the geographic regions and segments.
Zacks · 05/10 14:44
Research Alert: CFRA Keeps Hold Opinion On Adss Of Fresenius Medical Care
MT Newswires · 05/06 02:24
Fresenius Medical Care Non-GAAP EPS of €0.68, revenue of €4.55B
Fresenius Medical Care (NYSE:FMS): Q1 Non-GAAP EPS of €0.68. Revenue of €4.55B (+8.1% Y/Y). The Company expects revenue and net income to grow at low to mid-single digit percentage rates in FY
Seekingalpha · 05/04 13:32
Recap: Fresenius Medical Care Q1 Earnings
  Fresenius Medical Care (NYSE:FMS) reported its Q1 earnings results on Wednesday, May 4, 2022 at 08:00 AM. Here's what investors need to know about the announcement.
Benzinga · 05/04 13:19
Fresenius Medical Care's Q1 Adjusted Net Income Declines, Revenue Grows
MT Newswires · 05/04 11:12
Fresenius warns of bigger Ukraine war impact after Q1 profit beat
German healthcare group Fresenius's first-quarter profit exceeded market expectations on Wednesday, driven by growth in its generic infusion drugs unit in emerging markets. However, the group warned cost inflation and supply chain disruptions were likely ...
Reuters · 05/04 10:34
More
No Data
Learn about the latest financial forecast of FMS. Analyze the recent business situations of Fresenius Medi through EPS, BVPS, FPS, and other data. This information may help you make smarter investment decisions.
Analyst Rating

Based on 5 analysts

Hold

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

0.00%Strong Buy
0.00%Buy
80.00%Hold
0.00%Under-perform
20.00%Sell
Analyst Price Target
The average FMS stock price target is 33.20 with a high estimate of 35.51 and a low estimate of 30.74.
High35.51
Average33.20
Low30.74
Current 30.11
EPS
Actual
Estimate
0.140.280.410.55
Q2 2021
Q3 2021
Q4 2021
Q1 2022
Q2 2022
Institutional Holdings
Institutions: 271
Institutional Holdings: 31.16M
% Owned: 5.32%
Shares Outstanding: 586.05M
TypeInstitutionsShares
Increased
33
2.54M
New
11
28.65K
Decreased
17
6.06K
Sold Out
9
323.10K
  • Performance
  • Asset Allocation
  • Dividend History
No Data
Industry
Healthcare Facilities & Services
-0.47%
Healthcare Providers & Services
+0.58%
Key Executives
Chairman - Supervisory/Director
Dieter Schenk
Chairman - Management/Chief Executive Officer
Rice Powell
Non-Executive Chairman
Ben Lipps
Vice Chairman - Supervisory/Independent Director
Rolf Classon
Chief Financial Officer/Management Board
Helen Giza
Management Board
Frank Maddux
Management Board
Katarzyna Mazur-Hofsaess
Management Board
William Valle
Independent Director/Supervisory Board
Gregory Sorensen
Independent Director/Supervisory Board
Dorothea Wenzel
Independent Director/Supervisory Board
Pascale Witz
Supervisory Board
Gregor Zuend
No Data
No Data
About FMS
Fresenius Medical Care AG & Co. KGaA is a Germany-based kidney dialysis institute. The Company provides dialysis care and related services to persons suffering from end-stage renal disease (ESRD), as well as other healthcare services. The Company also develops and manufactures a wide variety of health care products, which includes dialysis and non-dialysis products. Its dialysis products include hemodialysis machines, peritoneal cyclers, dialyzers, peritoneal solutions and granulates, bloodlines, renal pharmaceuticals and systems for water treatment. Its non-dialysis products include acute cardiopulmonary and apheresis products. The Company supplies dialysis clinics it owns, operates or manages with a broad range of products, and sells dialysis products to other dialysis service providers.

Webull offers kinds of Fresenius Medical Care AG & Co. KGaA stock information, including NYSE:FMS real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, FMS stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading FMS stock methods without spending real money on the virtual paper trading platform.